Representations/Ethics and Disclosure/Sanctions Sample Clauses

POPULAR SAMPLE Copied 1 times
Representations/Ethics and Disclosure/Sanctions. The ‘Author(s)’ affirms the Author Representations noted below, and confirm that he/she has reviewed and complied with the relevant Instructions to Authors, Ethics in Publishing policy, Declarations of Interest disclosure and information for authors from countries affected by sanctions (Iran, Cuba, Sudan, Burma, Syria, or Crimea). Please note that the ‘Publisher’ may require that all co-authors sign and submit Declarations of Interest disclosure forms. The ‘Author(s)’ is also aware of the publisher’s policies with respect to: ▪ Retractions and withdrawal: Only used for Articles in Press which represent early versions of articles and sometimes contain errors, or may have been accidentally submitted twice. Occasionally, but less frequently, the articles may represent infringements of professional ethical codes, such as multiple submission, bogus claims of authorship, plagiarism, fraudulent use of data or the like. Articles in Press (articles that have been accepted for publication but which have not been formally published and will not yet have the complete volume/issue/page information) that include errors, or are discovered to be accidental duplicates of other published article(s), or are determined to violate our journal publishing ethics guidelines in the view of the editors (such as multiple submission, bogus claims of authorship, plagiarism, fraudulent use of data or the like), may be ‘Withdrawn’ from ASERS Publishing. Withdrawn means that the article content (HTML and PDF) is removed and replaced with a HTML page and PDF simply stating that the article has been withdrawn according to the ASERS Publishing Policy on Article in Press Withdrawal with a link to the current policy document. The ‘Author(s)’ could withdrawal the ‘Article’ before acceptation for publication for objective reasons, and the withdrawal must be made written to the Editor in Chief of the Journal. In case that the ‘Author(s)’ withdrawal the ‘Article’ after the acceptation and the payment of publication fee has been performed, ASERS Publishing will not refund the publication fee. The refund of publication fee could be possible only in case in which the ‘Publisher’ will not publish the ‘Article’ for any reasons, except the situation of plagiarism detection after the payment, or dual publication in any language of the same ‘Article’. In such a cases, the ‘Publisher’ will retract the paper from the Journal, webpage and databases in which the Journal is indexed without any compensation fo...
View SourceView Similar (14)
Representations/Ethics and Disclosure/Sanctions. The ‘Author(s)’ affirms the Author Representations noted below and confirm that he/she has reviewed and complied with the relevant Instructions to Authors, Ethics in Publishing policy, Declarations of Interest disclosure and information for authors from countries affected by sanctions (Russia, Iran, Cuba, North Korea, Democratic Republic of Congo, Sudan, Somalia, Nicaragua, Burma, Syria, Venezuela, Zimbabwe, or Belarus). Please note that the ‘Publisher’ may require that all co-authors sign and submit Declarations of Interest disclosure forms. The ‘Author(s)’ is also aware of the publisher’s policies with respect to:
View SourceView Similar (5)
Representations/Ethics and Disclosure/Sanctions. I affirm the Author Representations noted below, and confirm that I have reviewed and complied with the relevant Instructions to Authors, Ethics in Publishing policy, Declarations of Interest disclosure and information for authors from countries affected by sanctions. Please note that some journals may require that all co-authors sign and submit Declarations of Interest disclosure forms. I am also aware of the publisher’s policies with respect to retractions and withdrawal (▇▇▇▇▇://▇▇▇.▇▇▇▇▇▇▇▇.▇▇▇/about/our-business/policies/article-withdrawal). For further information see the publishing ethics page at ▇▇▇▇▇://▇▇▇.▇▇▇▇▇▇▇▇.▇▇▇/about/our-business/policies/publishing-ethics and the journal home page. For further information on sanctions, see ▇▇▇▇▇://▇▇▇.▇▇▇▇▇▇▇▇.▇▇▇/about/our-business/policies/trade-sanctions. • The Article I have submitted to the journal for review is original, has been written by the stated authors and has not been previously published. • The Article was not submitted for review to another journal while under review by this journal and will not be submitted to any other journal. • The Article and the Supplemental Materials do not infringe any copyright, violate any other intellectual property, privacy or other rights of any person or entity, or contain any libellous or other unlawful matter. • I have obtained written permission from copyright owners for any excerpts from copyrighted works that are included and have credited the sources in the Article or the Supplemental Materials. • Except as expressly set out in this Journal Publishing Agreement, the Article is not subject to any prior rights or licenses • If I and/or any of my co-authors reside in Iran, Cuba or Syria the Article has been prepared in a personal, academic or research capacity and not as an official representative or otherwise on behalf of the relevant government or institution. • If I am using any personal details or images of patients, research subjects or other individuals, I have obtained all consents required by applicable law and complied with the publisher’s policies relating to the use of such images or personal information. See ▇▇▇▇▇://▇▇▇.▇▇▇▇▇▇▇▇.▇▇▇/about/our-business/policies/patient-consent for further information. • Any software contained in the Supplemental Materials is free from viruses, contaminants or worms. • If the Article or any of the Supplemental Materials were prepared jointly with other authors, I have informed the co-author(s) of the terms of thi...
View SourceView Similar (4)
Representations/Ethics and Disclosure/Sanctions. The ‘Author(s)’ affirms the Author Representations noted below, and confirm that he/she has reviewed and complied with the relevant Instructions to Authors, Ethics in Publishing policy, Declarations of Interest disclosure and information for authors from countries affected by sanctions (Iran, Cuba, Sudan, Burma, Syria, or Crimea). Please note that the ‘Publisher’ may require that all co-authors sign and submit Declarations of Interest disclosure forms. The ‘Author(s)’ is also aware of the publisher’s policies with respect to:
View Source

Related to Representations/Ethics and Disclosure/Sanctions

  • Identification and Disclosure of Privacy and Security Offices Business Associate and Subcontractors shall provide, within ten (10) days of the execution of this agreement, written notice to the Covered Entity’s contract/grant manager the names and contact information of both the HIPAA Privacy Officer and HIPAA Security Officer. This information must be updated any time either of these contacts changes.

  • Publicity and Disclosures No press releases or public disclosure, either written or oral, of the transactions contemplated by this Agreement, shall be made by a party to this Agreement without the prior knowledge and written consent of Buyer and the Company.

  • Public Statements and Disclosure The initial press release concerning this Agreement and the Merger will be a joint press release reasonably acceptable to the Company and Parent and will be issued promptly following the execution and delivery of this Agreement. Thereafter, unless the Company Special Committee has made a Company Recommendation Change, the Company and its Representatives, on the one hand, and Parent and Merger Sub and their respective Representatives, on the other hand, will consult with the other Parties before (a) participating in any media interviews; (b) engaging in any meetings or calls with analysts, institutional investors or other similar Persons; or (c) providing any statements that are public or are reasonably likely to become public, in each case to the extent relating to this Agreement or the Merger and neither party shall issue any press release or make any public announcement or statement without the consent of the other party, which shall not be unreasonably withheld, conditioned or delayed; provided, that to the extent such release or announcement is required by applicable Law or any listing agreement with or rule of any national securities exchange or association upon which the securities of the Company are listed, the party required to make the release, announcement or statement shall use reasonable best efforts to consult with the other Party about, and allow the other Party reasonable time (taking into account the circumstances) to comment on, such release, announcement or statement in advance of such issuance. Notwithstanding the foregoing, neither Parent nor the Company will be obligated to engage in such consultation with respect to communications that are (i) principally directed to its employees, drivers, suppliers, customers, partners or vendors so long as such communications are consistent with prior communications previously agreed to by Parent and the Company and do not add additional material information not included in such previous communication (in which case such communications may be made consistent with such plan); (ii) related to a Superior Proposal or Company Recommendation Change or, in each case, any action taken pursuant thereto; (iii) with respect to any dispute or Legal Proceeding solely among the Parties or their respective Affiliates related to this Agreement or the Transaction Documents; or (iv) substantively consistent with previous public disclosures made by the Parties in compliance with this Section 6.13 and which do not add additional material information not included in such previous disclosure. Parent will not be obligated to engage in such consultation with respect to communications that are principally directed to its existing or prospective equity holders and investors of Parent or its Affiliates, so long as such communications are consistent with prior communications previously agreed to by Parent and the Company and do not add additional material information not included in such previous communication.

  • REPORTS AND DISCLOSURE UNDER THE SECURITIES ACTS With a view to making available to the Investor the benefits of Rule 144 promulgated under the Securities Act or any other similar rule or regulation of the SEC that may at any time permit the Investor to sell securities of the Company to the public without registration (“Rule 144”), the Company agrees, at the Company’s sole expense, to: a. make and keep public information available, as those terms are understood and defined in Rule 144; b. file with the SEC in a timely manner all reports and other documents required of the Company under the Securities Act and the Exchange Act so long as the Company remains subject to such requirements and the filing of such reports and other documents is required for the applicable provisions of Rule 144; c. furnish to the Investor so long as the Investor owns Registrable Securities, promptly upon request, (i) a written statement by the Company that it has complied with the reporting and or disclosure provisions of Rule 144, the Securities Act and the Exchange Act, (ii) a copy of the most recent annual or quarterly report of the Company and such other reports and documents so filed by the Company, and (iii) such other information as may be reasonably requested to permit the Investor to sell such securities pursuant to Rule 144 without registration; and d. take such additional action as is requested by the Investor to enable the Investor to sell the Registrable Securities pursuant to Rule 144, including, without limitation, delivering all such legal opinions, consents, certificates, resolutions and instructions to the Company’s Transfer Agent as may be requested from time to time by the Investor and otherwise fully cooperate with Investor and Investor’s broker to effect such sale of securities pursuant to Rule 144. The Company agrees that damages may be an inadequate remedy for any breach of the terms and provisions of this Section 8 and that Investor shall, whether or not it is pursuing any remedies at law, be entitled to equitable relief in the form of a preliminary or permanent injunctions, without having to post any bond or other security, upon any breach or threatened breach of any such terms or provisions.

  • Confidentiality and Disclosure of Offering Materials by Potential Investor Potential Investor acknowledges on behalf of itself and any and all Related Parties that the Offering Materials are considered confidential and proprietary information of Owner and/or JLL, and Potential Investor will not make (or cause or permit any Related Party to make) any Offering Materials available, or disclose any of the contents thereof, to any person without Owner’s or JLL’s prior written consent; provided, however, that the Offering Materials may be disclosed to the Potential Investor’s Representative (if any), the Potential Investor's partners, employees, legal counsel, advisors, institutional lenders and other capital sources (collectively the "Related Parties") as reasonably required for an evaluation of the Property. Such Related Parties shall be informed by Potential Investor of the confidential nature of the Offering Materials and the terms of this Agreement and shall be directed by Potential Investor to keep the Offering Materials and related information strictly confidential in accordance with this Agreement and to otherwise abide by the terms of this Agreement as if such party was the Potential Investor hereunder. In the event any Related Party shall take or omit to take any action which if taken or omitted to be taken by Potential Investor would constitute a breach of or a default under the terms hereof, the such act or omission by such Related Party shall be deemed to be a breach of the terms hereof by Potential Investor.